Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds

Curr Med Chem. 2021;28(5):940-962. doi: 10.2174/0929867327666200306120151.

Abstract

As nitrogen-containing five-membered heterocyclic structural units, the substituted pyrazole derivatives have a broad spectrum of pharmacological activities, especially 4,5-dihydro-1H-pyrazoles that also commonly known as 2-pyrazolines. Since 2010, considerable studies have been found that the 2-pyrazoline derivatives possess potent anticancer activities. In the present review, it covers the pyrazoline derivatives reported by literature from 2010 till date (2010-2019). This review aims to establish the relationship between the anticancer activities variation and different substituents introduced into a 2-pyrazoline core, which could provide important pharmacophore clues for the discovery of new anticancer agents containing 2-pyrazoline scaffold.

Keywords: 2-pyrazoline; 4; 5-dihydro-1H-pyrazole; Nitrogencontaining heterocyclic structural units; SAR; anticancer activities; derivatives; synthesis.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Humans
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents